AXA IM Alts to invest €1.9 billion in Life Sciences through Kadans Science Partner
AXA IM Alts has raised €1.9 billion of equity to accelerate investments into the Life Sciences sector. The capital raised will primarily be invested through Kadans Science Partner, which will enable Kadans to execute